Bulletin
Investor Alert

New York Markets Close in:

AstraZeneca PLC ADR

NAS: AZN

GO
/marketstate/country/us

Market open

 --Real time quotes

May 13, 2021, 1:06 p.m.

AZN
/zigman2/quotes/200304487/composite

$

54.97

Change

+0.47 +0.85%

Volume

Volume 4.24m

Real time quotes

/zigman2/quotes/200304487/composite

Previous close

$ 54.50

$ 54.97

Change

+0.47 +0.85%

Day low

Day high

$54.43

$55.21

Open

52 week low

52 week high

$46.48

$64.94

Open

Company Description

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquart...

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Valuation

P/E Current

41.02

P/E Ratio (with extraordinary items)

34.13

P/E Ratio (without extraordinary items)

38.56

Price to Sales Ratio

4.47

Price to Book Ratio

8.41

Price to Cash Flow Ratio

25.45

Enterprise Value to EBITDA

17.80

Enterprise Value to Sales

4.89

Total Debt to Enterprise Value

0.14

Efficiency

Revenue/Employee

282,763.00

Income Per Employee

32,750.00

Receivables Turnover

5.35

Total Asset Turnover

0.45

Liquidity

Current Ratio

0.96

Quick Ratio

0.76

Cash Ratio

0.39

Profitability

Gross Margin

74.01

Operating Margin

16.98

Pretax Margin

14.29

Net Margin

11.58

Return on Assets

5.24

Return on Equity

23.36

Return on Total Capital

14.29

Return on Invested Capital

10.66

Capital Structure

Total Debt to Total Equity

130.46

Total Debt to Total Capital

56.61

Total Debt to Total Assets

30.54

Long-Term Debt to Equity

115.18

Long-Term Debt to Total Capital

49.98

Officers and Executives

Name Age Officer Since Title
Dr. Pascal Soriot 60 2012 Chief Executive Officer & Executive Director
Ms. Pam P. Cheng 49 2015 Executive VP-Operations & Information Technology
Mr. Marc Pierre Jean Dunoyer 68 2013 Executive VP-Global Portfolio & Product Strategy
Dr. Henry D. Cremisi - - Medical Director
Dr. Menelas N. Pangalos - 2010 EVP-Biopharmaceuticals Research & Development

Insider Actions

– Purchase – Sale 1 – Number of Transactions
/news/latest/company/us/azn

MarketWatch News on AZN

  1. Moderna Inc. stock underperforms Wednesday when compared to competitors

    4:31 p.m. May 12, 2021

    - MarketWatch Automation

  2. Moderna Inc. stock rises Tuesday, outperforms market

    4:31 p.m. May 11, 2021

    - MarketWatch Automation

  3. The Logic Behind the Tech Rout

    4:24 p.m. May 11, 2021

  4. Wall Street Now Expects Big Sales of Covid Vaccines Next Year

    11:30 a.m. May 11, 2021

    - Josh Nathan-Kazis

  5. Moderna Inc. stock underperforms Monday when compared to competitors

    4:31 p.m. May 10, 2021

    - MarketWatch Automation

  6. What BioNTech’s Earnings Mean for the Drug Makers

    10:12 a.m. May 10, 2021

    - Josh Nathan-Kazis

  7. EU Ditches AstraZeneca Vaccine. It's Pivoting to Pfizer.

    8:21 a.m. May 10, 2021

    - Josh Nathan-Kazis

  8. COVID-19 was never going to have a tidy Hollywood ending

    6:04 p.m. May 8, 2021

    - Quentin Fottrell

  9. Loading more headlines...
/news/nonmarketwatch/company/us/azn

Other News on AZN

  1. Modi Declared Victory, Then Covid Struck Back With a Vengeance

    57 min ago

    - Sadanand Dhume

  2. Pfizer (PFE) COVID-19 Vaccine for Adolescents Endorsed by CDC

    11:13 a.m. Today

    - Zacks.com

  3. Blood Expert Says He Found Why Some Vaccines Trigger Clots

    6:18 a.m. Today

    - Bojan Pancevski

  4. 2 Hyper-Growth Blue Chips For A Rich Retirement

    5:15 a.m. Today

    - Seeking Alpha

  5. Is Sanofi a Good Buy in 2021?

    6:20 a.m. May 12, 2021

    - Motley Fool

  6. Greensill Capital Is Target of U.K. Government Probe

    3:06 p.m. May 11, 2021

    - Julie Steinberg

  7. Seychelles Sees Renewed Covid-19 Surge Despite Vaccinations

    2:04 p.m. May 10, 2021

    - Nicholas Bariyo

  8. 7 Stocks Most at Risk of a Capital Gains Tax Selloff 

    1:08 p.m. May 10, 2021

    - InvestorPlace.com

  9. Some Countries Shift Guidance on AstraZeneca Vaccine

    1:56 p.m. May 9, 2021

    - Kim Mackrael

  10. 5 Unbeatable Stocks to Buy for a Biden Bull Market

    5:51 a.m. May 9, 2021

    - Motley Fool

  11. Loading more headlines...

At a Glance

AstraZeneca Plc

Cambridge Biomedical Campus

1 Francis Crick Avenue

Cambridge, Cambridgeshire CB2 0AA

Phone

44 2037495000

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

Revenue

$21.52B

Net Income

$2.49B

2020 Sales Growth

12.6%

Employees

76,100

/news/pressrelease/company/us/azn

Press Releases on AZN

  1. Smart Inhalers Market Analysis, Competitive Strategies and Forecasts to 2025

    9:18 a.m. Today

    - Market Insight Reports

  2. Global Meningioma Drug Market Size, Share, Value, and Competitive Landscape 2024

    8:45 a.m. Today

    - Heraldkeepers

  3. Loading more headlines...
Link to MarketWatch's Slice.